WELL.TO
WELL Health Technologies Corp.
TorontoCADEQUITY
Healthcare
DELAYED
Last price
4.53
▲ 0.02 (0.44%)
MARKET · —
Price
Open
4.53
Prev close
4.51
Day high
4.53
Day low
4.35
Volume
5.51M
Market cap
$1.16B
P/E (TTM)
226.50
52W range
3.58 – 6.08
Trailing performance
Returnvs SPY
1W
+2.03%
+3.4%
1M
+11.58%
+7.8%
3M
+8.63%
+5.5%
6M
+13.82%
+2.8%
YTD
+13.53%
+1.2%
1Y
-6.79%
-26.8%
3Y
+7.35%
-66.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.16B
Enterprise value$2.15B
Revenue (TTM)$1.52B
Gross profit$684.21M
EBITDA$174.53M
Net income$3.77M
EPS (TTM)$0.02
Free cash flow$1.65M
Total cash$130.64M
Total debt$954.13M
Book value / share$3.40
Shares outstanding255.95M
Float234.62M
Short % of float—
Dividend yield—
Beta (5Y)1.29
Valuation & profitability ratios
Trailing P/E226.50
Forward P/E12.30
PEG ratio—
Price / sales—
Price / book1.33
EV / revenue1.42
EV / EBITDA12.35
Gross margin45.07%
Operating margin5.06%
Profit margin0.25%
Return on equity1.64%
Return on assets2.65%
Debt / equity95.43
Current ratio0.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $1.40B | $919.69M | $776.05M | $569.14M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$7.36M | $32.61M | $82.00K | $1.37M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$7.36M | $32.61M | $82.00K | $1.37M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.06 | 0.04 | -27.9% |
| Mar 2026 | 0.06 | 0.06 | -0.5% |
| Dec 2025 | 0.11 | 0.20 | +88.2% |
| Sep 2025 | 0.10 | 0.16 | +67.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.06 | 9 | $408.73M | +12.1% |
| Next quarter | 0.08 | 8 | $429.04M | +11.5% |
| Current year | 0.25 | 10 | $1.60B | +14.4% |
| Next year | 0.37 | 8 | $1.72B | +7.6% |
Analyst targets & ownership
Mean target$7.27
High target$8.50
Low target$5.00
Implied upside60.38%
Analyst count13
ConsensusSTRONG BUY
Strong buy / Buy4 / 8
Hold1
Sell / Strong sell0 / 0
Held by insiders21.07%
Held by institutions3.57%
Institutions holding50
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
53.92M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 31, 26 | Javidan (Amir) Senior Officer of Issuer |
— | 16.67K | — | Direct |
| Jul 31, 26 | Javidan (Amir) Senior Officer of Issuer |
SELL | 9.46K | $26.91K | Direct |
| Jul 31, 26 | Javidan (Amir) Senior Officer of Issuer |
— | 16.67K | — | Direct |
| Jul 31, 26 | Javidan (Amir) Senior Officer of Issuer |
SELL | 9.46K | $26.91K | Direct |
| Jul 31, 26 | WELL Health Technologies Corp Issuer |
BUY | 2.40K | $6.75K | Direct |
| Jul 31, 26 | WELL Health Technologies Corp Issuer |
— | 2.40K | — | Direct |
| Jul 31, 26 | Fong (Eva) Senior Officer of Issuer |
— | 16.67K | — | Direct |
| Jul 31, 26 | Fong (Eva) Senior Officer of Issuer |
— | 16.67K | — | Direct |
| Jul 30, 26 | WELL Health Technologies Corp Issuer |
BUY | 2.40K | $6.74K | Direct |
| Jul 30, 26 | WELL Health Technologies Corp Issuer |
— | 2.40K | — | Direct |
| Jul 29, 26 | WELL Health Technologies Corp Issuer |
BUY | 2.40K | $6.76K | Direct |
| Jul 29, 26 | WELL Health Technologies Corp Issuer |
— | 2.40K | — | Direct |
| Jul 28, 26 | WELL Health Technologies Corp Issuer |
BUY | 2.40K | $6.70K | Direct |
| Jul 28, 26 | WELL Health Technologies Corp Issuer |
— | 2.40K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Cawkell (Kenneth Anthony) |
Director of Issuer | 363.12K | Exercise of rights |
Fong (Eva) |
Senior Officer of Issuer | 2.06M | Exercise of rights |
Javidan (Amir) |
Senior Officer of Issuer | 2.12M | Exercise of rights |
Kim, John |
Director of Issuer | 443.19K | Exercise of rights |
Lau (Sybil E Jen) |
Director of Issuer | 602.89K | Exercise of rights |
Liston (Thomas Craig) |
Director of Issuer | 705.19K | Exercise of rights |
McCarville (Tara) |
Director of Issuer | 162.70K | Exercise of rights |
WELL Health Technologies Corp |
Issuer | 2.40K | Redemption, retraction, cancelation, repurchase |
Moving averages & technicals
SMA 10
4.35
+4.07% from price
SMA 20
4.19
+8.00% from price
SMA 50
4.23
+7.15% from price
SMA 100
4.22
+7.23% from price
SMA 200
4.14
+9.52% from price
EMA 12
4.34
+4.29% from price
EMA 26
4.26
+6.23% from price
EMA 50
4.24
+6.74% from price
RSI (14)
66.0
Neutral
MACD (12,26,9)
0.08
Hist 0.05
ATR (14)
0.15
3.39% of price
Realised vol 30D
30.9%
Annualised
Bollinger upper
4.57
20, 2σ
Bollinger lower
3.81
20, 2σ
50 / 200 cross
Golden
4.23 vs 4.14
Trend bias
Above 200
+9.52%
Risk profile
Beta vs SPY
0.99
Less volatile than market
Correlation to SPY
0.32
Loosely linked
Realised vol 30D
30.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-39.4%
Peak to trough
Max drawdown 5Y
-68.1%
Peak to trough
ATR 14
0.15
3.39% of price
Beta (reported)
1.29
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
CoreWeave CEO Michael Intrator Sold Over 13,000 Shares for $1.2 Million. What Does This Mean for Investors?
Motley Fool · 5m ago
Warren Buffett's Hand-Picked Successor, Greg Abel, Has 72% of Berkshire Hathaway's Portfolio Invested in Just 5 Stocks. Here's My Top Pick for August.
Motley Fool · 5m ago
Tariffs just pushed Hyundai deeper into America
TheStreet · 8m ago
U.S. Steel Stocks Nucor, Steel Dynamics: Big Winners As Canada Trade Talks Collapse?
Investor's Business Daily · 9m ago
Insider Liquidates More Than 26,000 Shares of Fintech Stock for Tax Obligations
Motley Fool · 10m ago
The Games DEA Attorneys Play: What Marijuana Rescheduling Closing Brief Didn't Tell Judge Julius
ACCESS Newswire · 10m ago
Lindsay Clancy prosecutor keeps wearing hair bows. Here's why
USA TODAY · 10m ago
ThinkCareBelieve: https://thinkcarebelieve.blog/2026/08/21/week-83-of-the-trump-47-administration/
GlobeNewswire · 15m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.